Director of Quality Control

We are a fast-growing and dynamic organization seeking a Director, Quality Control to join our CMC team. The Director, Quality Control will provide strategic leadership in managing a growing team of scientists responsible for QC-related activities and operations. This individual will be responsible for providing scientific leadership, defining QC strategy and determining a roadmap for QC related activities and operations to meet corporate objectives.

The scope of this role covers all phases of product development (clinical and commercial) at Omeros for both large and small pharmaceutical products.

Good things are happening at Omeros!

Omeros is an innovative biotechnology company that discovers, develops, and commercializes first-in-class small-molecule and protein therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. Omeros’ lead lectin pathway inhibitor YARTEMLEA®, which inhibits the pathway’s effector enzyme MASP‑2, is FDA-approved for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA‑TMA) in adult and pediatric patients ages two years and older, with a planned U.S. launch in January 2026.

A marketing authorization application for YARTEMLEA in TA‑TMA is currently under review by the European Medicines Agency, with a decision expected in mid‑2026. OMS
1029, Omeros’ long‑acting MASP‑2 inhibitor, has successfully completed Phase 1 clinical trials.

Under a recently announced asset purchase and licensing agreement, Novo Nordisk acquired global rights to zaltenibart (formerly OMS
906), a MASP‑3 inhibitor in clinical development for PNH and other alternative pathway indications, along with associated intellectual property and related assets. Omeros’ pipeline also includes OMS
527, a phosphodiesterase 7 inhibitor in clinical development for cocaine use disorder and fully funded by the National Institute on Drug Abuse, as well as a growing portfolio of novel molecular and cellular oncology programs. For more information about Omeros and its programs, visit

• Lead Quality Control (QC) activities for clinical and commercial products, including management of in-process and release testing of GMP products
• Lead and manage QC staff including hiring, developing, evaluating and goal setting
• Oversee GMP clinical and commercial stability planning, execution, statistical data analysis and data trending in support of product expiry/shelf-life determination
• Oversee Quality Control requirements for compliance with cGMP regulations at external contract manufacturing and testing organizations
• Oversee product release and stability specification setting and COA generation
• Oversee and approve release of QC components of GMP manufacturing batch and test records at external contract organizations
• Develop Quality Control strategy and direction in conjunction with the development of analytical methods and manufacturing processes by the Omeros Technical CMC teams
• Partner with internal and external stakeholders to transfer, qualify and validate analytical methods
• Establish and maintain quality control standards applicable to the clinical and commercial product phases
• Author/review relevant sections of regulatory filing reports and submissions
• Drive continuous improvement projects in collaboration with internal and external stakeholders

• PhD in Analytical Chemistry, Biochemistry, Biology or a related scientific field
• 10+ years Quality Control experience is required, preferably with both biologics and small molecules
• Strong knowledge of GMPs, ICH guidelines and Quality management systems
• Experience with analytical methods technology transfer to third parties
• Experience with regulatory authority meetings and GMP site inspections
• Extensive experience with analytical method development and validation
• Expertise with stability testing, data trending and expiry setting strategy
• Experience with testing injectable and oral dosage forms preferred
• Experience in big pharma/biotech; experience in a startup biopharma company…